Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit — Stella

Home/Genitourinary Syndrome of Menopause/Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

View on ClinicalTrials.gov

Recruiting

Back to Genitourinary Syndrome of Menopause trials

Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Spain

Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus, Barcelona

Key details

Phase

Post-approval study

Sponsor

Fundación Santiago Dexeus Font

Collaborators

Regen Lab SA

Enrollment target

~192 participants

Started

May 2024

Primary completion

May 2026

Age range

18 Years – 70 Years

Sex

Female only

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.